Small GTPases is converting to Open Access from its 2023 volume.
Small GTPases is building on its strong foundation established over 12 years of reporting leading research by transitioning to an Open Access publishing format. The conversion to Open Access will help ensure that research published in Small GTPases will be fully accessible to all interested readers, with no barriers limiting global reach and impact. The market-leading web platform provided by Taylor & Francis, our innovative communications strategy and dedicated communications account will enable publications in Small GTPases to reach the widest possible audience.
Under the direction of the Editor-in-Chief Michael Olson, Professor of Chemistry and Biology at Toronto Metropolitan University and Canada Research Chair in Molecular Cell Biology, and supported by the diverse international editorial board, Small GTPases will continue to be a dedicated forum for the sharing of information at the forefront of the field, covering a broad range of research including cell and in vivo biology, structural studies, biochemistry, and drug discovery. In addition to the GTPase proteins themselves, Small GTPases features research focused on the structure, regulation, and function of their regulators and effectors.
The journal will maintain its notable track record of providing rapid peer review, undertaken by leading researchers from around the world to ensure rigorous evaluation and subsequent publication of high quality and robust research articles. In addition to research articles, Small GTPases will continue to publish timely reviews, mini‐reviews and commentaries that provide background and context for new discoveries. The success of our reviews as foundational in their respective fields is reflected in their high citation rates.
From 29th June, all manuscripts submitted to the journal will, if accepted, be required to pay an article publishing charge (APC) which can be covered by an author’s funder or institution. We look forward to receiving your submissions and welcome your support in this exciting new open access chapter for the journal.